HOMEOKINETIC CLASSIFICATION OF MENOPAUSAL SYNDROME TAKING INTO ACCOUNT THE «VEGETATIVE PASSPORT» AND THE FORM OF COMORBIDITY
DOI:
https://doi.org/10.11603/24116-4944.2025.2.15795Keywords:
menopausal syndrome, homeokinetic classification, «vegetative passport», comorbidity, sympathotonia, vagotonia, rehabilitationAbstract
The aim of the study – development and discussion of the homeokinetic/pathogenetic classification of menopausal syndrome (MPS) taking into account the «vegetative passport», impaired homeokinesis parameters, and the form of comorbidity.
Materials and Methods. The basic results for the MPS classification were obtained at the clinical departments of DNMU and at the Medical Rehabilitation Center «Drive-Medical» (n=65). 47 practically healthy people formed the control group. Patients with MPS were divided into two groups according to heart rate variability (HRV) spectral analysis data and automated determination of the «vegetative passport». The form of comorbidity was established by the level of intracellular calcium in the hair (MAB-diagnosis). Computer electrocardiographs «ANS-Pro» and «Cardiolab-2000» were used. Statistical processing was carried out using ANOVA/MANOVA, correlation and regression analysis.
Results and Discussion. The conducted studies allowed us to formulate vagotonic and sympathotonic homeokinesis, the form of MPS and comorbidity. Sympathotonics are prone to calcium-excessive comorbidity (atherosclerosis), oxidative damage, dominance of catabolic hormones, acidosis, which forms MPS with relative estrogen deficiency. Vagotonics are prone to calcium-deficient comorbidity (osteoporosis), autoimmune aggression, dominance of anabolic hormones, alkalosis, which forms MPS with absolute estrogen deficiency. The proposed homeokinetic classification takes into account the «vegetative passport», the form of comorbidity, and the impairment of homeokinesis parameters.
Conclusions. Taking into account the homeokinetic classification of MPS, clinical tests for determining the «vegetative passport», the form of somatogenia, and typical clinical syndromes have been developed, which allows for compiling a rehabilitation diagnosis and predicting rehabilitation tactics.
References
Sokrut, M.V., Hozhenko, A.I., Klymovitskyi, F.V., Sokrut, V.M., Sokrut, O.P., Popov, V.M., ... & Liakh, Yu.Ye. (2024). Porushennia parametriv homeokinezu pry patolohii suhlobiv ta yikh endoprostezuvanni: naukova monohrafiia [Violation of homeocinesis parameters in joint pathology and their endoprosthetics: a scientific monograph]. Lviv: PP «Magnoliia 2006» [in Ukrainian].
Wang, L., Xu, S., Chen, R., Ding, Y., Bao, M., He, B., et al. (2024). Exploring the causal association between epigenetic clocks and menopause age: insights from a bidirectional Mendelian randomization study. Front Endocrinol (Lausanne), 15, 1429514. DOI: 10.3389/fendo.2024.1429514. DOI: https://doi.org/10.3389/fendo.2024.1429514
Fang, Y., Liu, F., Zhang, X., et al. (2024). Mapping global prevalence of menopausal symptoms among middleaged women: a systematic review and metaanalysis. BMC Public Health, 24, 1767.
Han, X., Gu, Y., Li, T., Qian, H., Wang, J., & Huang, X. (2023). Neuroendocrine pathogenesis of perimenopausal depression: epigenetics, monoamines, neuroinflammation and HPA HPG axis interactions. Front Psychiatry, 14. 1162501. DOI: 10.3389/fpsyt.2023.1162501. DOI: https://doi.org/10.3389/fpsyt.2023.1162501
Zhao, D., Lv, G., Zhang, Y., Xie, Z., Wang, Q., Zhou, M., & Li, P. (2021). Identifying the different subtypes in menopausal symptoms among middle-aged women in China: a latent class analysis. Menopause, 28(12), 1418–1427. DOI: 10.1097/GME.0000000000001864. DOI: https://doi.org/10.1097/GME.0000000000001864
Fang, Y., Liu, F., Zhang, X., Chen, L., Liu, Y., Yang, L., et al. (2024). Mapping global prevalence of menopausal symptoms among middle aged women: a systematic review and meta analysis. BMC Public Health, 24, 1767. DOI: 10.1186/s12889-024-19280-5. DOI: https://doi.org/10.1186/s12889-024-19280-5
Troisi López, E., Santos-Rodríguez, R., López-Alonso, A., González De la Calle, H., Martín-Ruiz, I., Martínez-Vázquez, C., et al. (2023). Cognition, mood and sleep in menopausal transition: the role of estrogen-mediated modulation of multiple neurotransmitter systems. Medicina (Kaunas), 59 (10), 668. DOI: 10.3390/medicina55100668. DOI: https://doi.org/10.3390/medicina55100668
Santos-Rodríguez, R., Troisi López, E., Blasco-Lafarga, C., Monferrer-Marín, J., et al. (2024). Blunted cardiac autonomic response to active standing in post menopausal women: evidence from heart rate variability analysis. Front Cardiovasc Med, 11, 1402086. DOI: 10.3389/fcvm.2024.1402086. DOI: https://doi.org/10.3389/fcvm.2024.1402086
Zhang, Y., Tan, X., & Tang, C. (2024). Estrogen immuno neuromodulation disorders in menopausal depression. J Neuroinflammation, 21, 159. DOI: 10.1186/s12974-024-03152-1. DOI: https://doi.org/10.1186/s12974-024-03152-1
Zhang, G.-Q., Chen, J.-L., Luo, Y., Mathur, M.B., Anagnostis, P., Nurmatov, U., et al. (2021). Menopausal hormone therapy and women’s health: An umbrella review. PLoS Med, 18(8), e1003731. DOI: 10.1371/journal.pmed.1003731. DOI: https://doi.org/10.1371/journal.pmed.1003731
Sokrut, V.M. (n.d.). Klinichnyi test vyznachennia formy somatohenii [Clinical test for determining the form of somatogeny]. Retrieved from: https://sokrut.com/somatogenytest2 [in Ukrainian].
Sokrut, M.V. (2021). Elementoz pry patolohii suhlobiv ta endoprotezuvanni: monohrafiia [Elementosis in joint pathology and endoprosthetics: a monograph]. Sloviansk: Drukarskyi dvir. 218 [in Ukrainian].
Huang, Y., & Wang, Y. (2022). Vago-Sympathetic Index in Health and Disease: Implications for Clinical Practice. Clinical Autonomic Research, 32(2), 101-110.
Lehrer, P.M., et al. (2020). Heart Rate Variability Biofeedback Improves Emotional and Physical Health and Performance: A Systematic Review and Meta Analysis. Applied Psychophysiology and Biofeedback, 45(3), 109-129. DOI: 10.1007/s10484-020-09466-z. DOI: https://doi.org/10.1007/s10484-020-09466-z
Frasch, M.G., Courchesne, M., Cao, M.J., & Desrochers, A. (2023). Modulation of vagal activity may help reduce neurodevelopmental disorders in offspring exposed to pre-eclampsia. Frontiers in Immunology, 14, 1280334. DOI: 10.3389/fimmu.2023.1280334. DOI: https://doi.org/10.3389/fimmu.2023.1280334
Mai, K., Maverakis, E., Li, J., & Zhao, M. (2023). Maintaining and Restoring Gradients of Ions in the Epidermis: The Role of Ion and Water Channels in Acute Cutaneous Wound Healing. Advances in Wound Care (New Rochelle), 12(12), 696-709. DOI: 10.1089/wound.2022.0128. DOI: https://doi.org/10.1089/wound.2022.0128
Li, K., et al. (2022). The Predictive Value of Serum Calcium on Heart Rate Variability in Patients With Type 2 Diabetes Mellitus. Frontiers in Endocrinology, 13, Article 864008. Retrieved from: https://www.frontiersin.org/articles/10.3389/fendo.2022.864008/full. DOI: https://doi.org/10.3389/fendo.2022.864008
Paschou, S. A., Athanasiadou, K. I., & Papanas, N. (2024). Menopausal Hormone Therapy in Women with Type 2 Diabetes Mellitus: An Updated Review. Diabetes Therapy, 15, 741-748. DOI: 10.1007/s13300-024-01546-1. DOI: https://doi.org/10.1007/s13300-024-01546-1
Li, X., Zhang, J., Liu, Y., Song, Y., Wang, Q., et al. (2023). Role of vitamin D in menopausal women’s health: implications for calcium phosphate metabolism, immunity, and quality of life. Front Physiol, 14, 1211896. DOI: 10.3389/fphys.2023.1211896. DOI: https://doi.org/10.3389/fphys.2023.1211896
Du, Y., Qi, X., Zhang, L., Yang, Y., & Chen, T. (2023). Calcium influx–induced lytic cell death disrupts skin immune homeostasis. Cell Discovery, 9, Article 124. DOI: 10.1038/s41421-023-00623-2. DOI: https://doi.org/10.1038/s41421-023-00623-2
Nguyen, T.N., Zhang, R., & Sino, C. (2019). Correlation of somatic and psychological symptoms during menopausal transition: a systematic review. Menopause, 26(6), 666-676.
Carter, J. (2023). Vasomotor symptoms of menopause, autonomic dysfunction, and cardiovascular risk. Am J Physiol Heart Circ Physiol, 325(1), H15–H25.
Gasparyan, S.A., Chotchaeva, A.M., & Karpov, S.M. (2023). Cognitive and psychoemotional changes in menopausal transition: the possibility of medical correction. Probl Endokrinol, 69(1), 86-95. DOI: https://doi.org/10.14341/probl13205
Zhang, Y., Zhao, Z., & Sun, Y. (2023). Neuroendocrine mechanisms of perimenopausal depression: insights from epigenetics. Front Aging Neurosci, 15, 110.
Portman, D.J., & Bachmann, G.A. (2013). Ospemifene, a novel selective estrogen receptor modulator, for treating dyspareunia associated with postmenopausal vulvar and vaginal atrophy – results from a pivotal phase 3 randomized trial. Menopause, 20(6), 623-630. DOI: 10.1097/GME.0b013e3181c1ac01. DOI: https://doi.org/10.1097/gme.0b013e318279ba64
Kingsberg, S.A., Simon, J.A., Mirkin, S., Reiter, S., Lin, L., Kaunitz, A.M., et al. (2022). Efficacy and safety of ospemifene for treatment of dyspareunia associated with vulvovaginal atrophy: integrated analysis of two phase 3 trials. Menopause, 29(5), 485-492. DOI: 10.1097/GME.0000000000001925. DOI: https://doi.org/10.1097/GME.0000000000001925
Akhtar, S.M.M., Ali, A., Khan, M.S., et al. (2024). Efficacy and safety of fezolinetant for vasomotor symptoms in postmenopausal women: a systematic review and meta analysis. Int J Gynaecol Obstet, 166(3), 969-983. DOI: 10.1002/ijgo.15467. DOI: https://doi.org/10.1002/ijgo.15467
Lederman, S., Ottery, F.D., Cano, A., Santoro, N., Shapiro, M., Stute, P., et al. (2023). Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomized controlled study. Lancet, 401(10382), 1091-1102. DOI: 10.1016/S0140-6736(23)00085-5. DOI: https://doi.org/10.1016/S0140-6736(23)00085-5
Sokrut, V.M., Lytvynova, O.V., Sokrut, O.P., Mullakhmetov, A.H., Sokrut, M.V. (2025). Homeokinetychna klasyfikatsiya astmatychnoho syndromu z urakhuvannyam vehetatyvnoho pasporta i formy komorbidnosti [Homeokinetic classification of asthmatic syndrome taking into account the vegetative passport and the form of comorbidity]. Medychna nauka Ukrayiny [Medical Science of Ukraine], 21(3), 69-75. DOI: 10.32345/2664-4738.3.2025.07 [in Ukrainian]. DOI: https://doi.org/10.32345/2664-4738.3.2025.07
Eslick, E.M., Jones, G.L., & O’Connor, R. (2019). Sexual Dysfunction in Menopausal Women: Prevalence and Predictors. Climacteric, 22(5), 503-510.
Vehmas, T., Itkonen, L., & Lipsanen, S. (2021). Osteoporosis after menopause: diagnosis and treatment approaches. Maturitas, 147, 8-14.
Montoya-Estrada, A., García-Cortés, A.Y., Romo-Yañez, J., Ortiz-Luna, G.F., Arellano-Eguiluz, A., Belmont-Gómez, A., et al. (2024). The Administration of Resveratrol and Vitamin C Reduces Oxidative Stress in Postmenopausal Women – A Pilot Randomized Clinical Trial. Nutrients, 16(21), 3775. DOI: 10.3390/nu16213775. DOI: https://doi.org/10.3390/nu16213775
Moon, Y., Lee, E., Lee, S., Son, G.-I., Byeon, H., Shin,
H.-R., et al. (2023). Changes in cortisol awakening responses (CAR) in menopausal women through short-term marine healing retreat program with specific factors affecting each CAR index. PLoS One, 18(4), e0284627. DOI: 10.1371/journal.pone.0284627. DOI: https://doi.org/10.1371/journal.pone.0284627
Moshi, M.R., Nicolopoulos, K., Stringer, D., Ma, N., Jenal, M., & Vreugdenburg, T. (2023). The Clinical Effectiveness of Denosumab (Prolia®) for the Treatment of Osteoporosis in Postmenopausal Women, Compared to Bisphosphonates, Selective Estrogen Receptor Modulators, and Placebo: A Systematic Review and Network Meta-Analysis. Calcif Tissue Int, 112(6), 631-646. DOI: 10.1007/s00223-023-01078-z. DOI: https://doi.org/10.1007/s00223-023-01078-z
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 О. В. Литвинова, О. П. Сокрут, І. Р. Мисула, В. М. Сокрут, М. В. Сокрут, А. Г. Муллахметов
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish in this journal agree to the following terms:
1. The authors reserve the right to authorship of the work and pass the journal right of first publication of this work is licensed under a Creative Commons Attribution License, which allows others to freely distribute the work published with reference to the authors of the original work and the first publication of this magazine.
2. Authors are entitled to enter into a separate agreement on additional non-exclusive distribution of work in the form in which it was published in the magazine (eg work place in the electronic repository institution or publish monographs in part), provided that the reference to the first publication of this magazine.
3. Policy magazine allows and encourages authors placement on the Internet (eg, in storage facilities or on personal websites) manuscript of how to submit the manuscript to the editor and during his editorial processing, since it contributes to productive scientific discussion and positive impact on the efficiency and dynamics of citing published work (see. The Effect of Open Access).
